Not so fast! We need to get from here to there. Today, health/behavior monitoring and quantification sensors are all the rage. The Fitbit, a wearable sensor, is one of the more popular wearable tech devices for tracking your health. Fitbit tracks your activity (steps), diet, and even your sleep patterns. You can interact with the Fitbit using a series of tapping sequences and the Fitbit syncs all your data with your phone and computer. Then the process is to quantify, analyze, and optimize your wake and sleep life. Doing all this will not help you avoid your ultimate demise, but it could contribute to a longer life, and better yet, one where you're in better health along your life's time-line. The concept is that if you are monitoring your activity, food, and sleep, you can make adjustments to improve these areas; thus better health. The Fitbit Flex is only $99! Get started Buy directly from Fitbit
Is there a secret art to lip enhancement? You surely know when you've seen someone and immediately reacted, "she had her lips done!". What about the lips that have been filled, look terrific, and you don't know they've been enhanced with filler? That's the secret art to lip fillers and that is why it is critical to select a physician injector who knows the secrets. What are the secrets to getting great lip enhancements? First, experience! Second, the artist within! The injector must also understand the complex, and sometimes unforgiving, anatomy of the lips. These artistic and technical demands explain why so many patients receive sub-standard lip injections and are left with unnatural results. Patients often believe that lip enhancement always leads to unnatural, over-filled results; in actuality, this should never occur in experienced hands.
The Journal of Urology reports that prostate-specific antigen (PSA) testing has declined in the United States following a 2013 recommendation by the US Preventive Services Task Force (USPSTF)—a group of primary care physicians charged with developing recommendations about which preventative health screenings should be covered under the Affordable Health Care Act.
The U.S. Food and Drug Administration today expanded the approved use of Imbruvica (ibrutinib) to treat patients with chronic lymphocytic leukemia (CLL) who carry a deletion in chromosome 17 (17p deletion), which is associated with poor responses to standard treatment for CLL. Imbruvica received a breakthrough therapy designation for this use.
The FDA has approved over-the-counter Flonase Allergy Relief, or fluticasone propionate 50 mcg nasal spray, for treatment of hay fever or upper respiratory allergies, its maker GlaxoSmithKline announced.
House and Senate negotiators unveiled a $17 billion package to begin addressing long wait times and mismanagement at the Department of Veterans Affairs, a down payment on a broader reassessment of how the agency provides care to veterans.
Liberia closed most of its borders on Monday as West African governments struggled to prevent the spread of the extremely deadly Ebola virus, which has infected more than 1,000 people in three countries this year.
Kevin Fu, Ph.D., Associate Professor of Electrical Engineering and Computer Science at the University of Michigan and speaker at the 2014 Privacy & Security Forum in San Diego, addresses the vulnerabilities of medical devices and the potential risks to patients.
Expanding on a partnership announced this past spring, athenahealth and Henry Schein will integrate their respective technologies to better enable community health centers to meet reporting requirements.
[See also: Athenahealth reports Q2 gains]
Two of the nation's biggest entitlement programs are on very different paths, government trustees said Monday—with Medicare's trust fund rebounding strongly, but Social Security's disability fund on the brink of exhaustion.
In one of the largest prevalence studies to date, researchers from the UK provide national, regional, and global genotype prevalence estimates for the hepatitis C virus. Findings indicate that genotype 1 is the most prevalent worldwide, with over 83 million patients infected of which one-third reside in East Asia.
Two new pill-only antiviral drug regimens could provide shorter, more effective treatment options with fewer side effects for the majority of patients infected with hepatitis C, even those most difficult to treat, according to the results of two studies. Around 150 million people worldwide have chronic hepatitis C virus (HCV) infection, a condition that is a major cause of liver cirrhosis and liver cancer. In the USA, numbers of people with HCV-related liver failure and liver cancer are expected to treble by 2030 because of low treatment rates.
Following a healthy lifestyle may lower childhood cancer survivors’ risk of developing the metabolic syndrome, a study shows. The findings indicate that children with cancer and adults who had cancer when they were children should receive information about how their lifestyle may influence their long-term health.
When patients take too many unnecessary antibiotics it inches us ever closer to a world where essential drugs are no longer effective. More than two million people in the United States develop...
-- Read more on ScientificAmerican.com
Health Data Miner
For at least the last decade, the health IT field has seen a scholarly back-and-forth on the effectiveness of electronic medical records. As soon as one study is published that finds technology has little impact on patient outcomes, another emerges that seems to show just the opposite.